You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (58)

Journals (0)

1-10 of 58 results for partitioned survival models

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Impact of Limited Sample Size and Follow-up on Partitioned Survival and Multistate Modeling-Based Health Economic Models: A Simulation Study

Open access

Research article

First published 2025-8

Impact of Limited Sample Size and Follow-up on Partitioned Survival and Multistate Modeling-Based Health Economic Models: A Simulation Study

Jaclyn M. Beca, Kelvin K. W. Chan, David M. J. Naimark [...]

Medical Decision Making

Select article: Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling

Open access

Research article

First published 2017-5

Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling

Claire Williams, James D. Lewsey, Daniel F. Mackay [...]

Medical Decision Making

Select article: A Bayesian Framework for Patient-Level Partitioned Survival Cost-Utility Analysis

Open access

Research article

First published 2021-11

A Bayesian Framework for Patient-Level Partitioned Survival Cost-Utility Analysis

Andrea Gabrio

Medical Decision Making

Select article: Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China

Open access

Research article

First published 2024

Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China

Mengya Li, Xiaoyan Zhong, Chengbin Zhang [...]

Therapeutic Advances in Hematology

Select article: Recursive Partitioning Method on Competing Risk Outcomes

Open access

Research article

First published 2016

Recursive Partitioning Method on Competing Risk Outcomes

Wei Xu, Jiahua Che, Qin Kong

Cancer Informatics

Select article: Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis

Open access

Research article

First published 2026

Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis

Jia Wang, Baolong Ding, Zhuying Jing [...]

Therapeutic Advances in Medical Oncology

Select article: Cemiplimab combined with chemotherapy versus chemotherapy in advanced non-small cell lung cancer: an updated EMPOWER-Lung 3 trial-based cost-effectiveness analysis

Open access

Research article

First published 2023

Cemiplimab combined with chemotherapy versus chemotherapy in advanced non-small cell lung cancer: an updated EMPOWER-Lung 3 trial-based cost-effectiveness analysis

Gaofeng Zhu, Hongfu Cai, Zhiwei Zheng

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China

Open access

Research article

First published 2025

Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China

Baolong Ding, Hongting Yao, Tiantian Tao [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

Open access

Research article

First published 2023

Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

Ying-Tao Lin, Chong-Chong Zhou, Kai Xu [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma

Open access

Research article

First published 2025

Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma

Huimin Zou, Yunfeng Lai, Xianwen Chen [...]

Therapeutic Advances in Gastroenterology

1
2
3
•••
6
10 / page

Article type

Publication date

Subjects

Access